Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
100%(1 trials)

Phase Distribution

Ph early_phase_1
1
25%
Ph phase_2
2
50%
Ph phase_1
1
25%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Suspended1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 22 (50.0%)

Trials by Status

suspended125%
completed125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
suspendedphase_2

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

NCT04596644
recruitingphase_1

Cannabis Effects as a Function of Sex

NCT04385082
completedphase_2

Repeated Cannabis Administration on Experimental Pain and Abuse Liability

NCT04576507
recruitingearly_phase_1

Brain Mechanisms Supporting Cannabis-induced Pain Relief

NCT04982965

Clinical Trials (4)

Showing 4 of 4 trials
NCT04596644Phase 2

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

Suspended
NCT04385082Phase 1

Cannabis Effects as a Function of Sex

Recruiting
NCT04576507Phase 2

Repeated Cannabis Administration on Experimental Pain and Abuse Liability

Completed
NCT04982965Early Phase 1

Brain Mechanisms Supporting Cannabis-induced Pain Relief

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4